Conversely, pharmacological inhibition of the TGF-β signaling pathway using the SB-431542 inhibitor has been demonstrated to increase lifespan in ALS mice (Endo et al., 2015). This evidence concerns the gene TGFB1 and amyotrophic lateral sclerosis.